Overview

MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity

Status:
Completed
Trial end date:
2015-03-31
Target enrollment:
Participant gender:
Summary
This study is "A Prospective, Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Treatment of Post Stroke Upper Limb Spasticity".
Phase:
Phase 4
Details
Lead Sponsor:
Medy-Tox
Treatments:
Botulinum Toxins, Type A